immune-checkpoint

Documents about immune-checkpoint

• Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)#1371610ClinicalTrials.gov
• Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy#1009917ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma#835507ClinicalTrials.gov
• Abatacept in Immune Checkpoint Inhibitor Myocarditis#1213299ClinicalTrials.gov
• Real World Pharmacokinetics of Immune Checkpoint Inhibitors#992775ClinicalTrials.gov
• STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy#1094519ClinicalTrials.gov
• Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors#268893IRIS
• Immune Checkpoint Receptors in AML-Leukemic Initiating Cells#1095141ClinicalTrials.gov
• PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure#864722ClinicalTrials.gov
• JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis#1115001ClinicalTrials.gov
• Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors#1430668ClinicalTrials.gov
• Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)#994055ClinicalTrials.gov
• Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis#1307887ClinicalTrials.gov
• Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC#811484ClinicalTrials.gov
• Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study#1434276HAL (France)
• Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients#1093612ClinicalTrials.gov
• Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash#1421103ClinicalTrials.gov
• CTC Immune Checkpoint#1486799ClinicalTrials.gov
• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer#812371ClinicalTrials.gov
• Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors#1088261ClinicalTrials.gov
• A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy#448275ClinicalTrials.gov
• Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors#1141138ClinicalTrials.gov
• Machine learning approaches to predict early cardiac immune-related adverse events in patients receiving immune checkpoint inhibitors#1054557OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer#1500852IRIS
• Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy#1252600OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2#28318ClinicalTrials.gov
• Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer#1477006ClinicalTrials.gov
• Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis#1244655ClinicalTrials.gov
• PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer#6810OpenAlex
• Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscape.#412895PubMed
• Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer#1032878ClinicalTrials.gov
• A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).#1453428ClinicalTrials.gov
• Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics#1323671ClinicalTrials.gov
• The blockade of immune checkpoints in cancer immunotherapy#6784OpenAlex
• Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer#1196078ClinicalTrials.gov
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors#873179ClinicalTrials.gov
• Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma#902306ClinicalTrials.gov
• Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients#1074145ClinicalTrials.gov
• Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors#1452453ClinicalTrials.gov
• Predictive value of baseline eosinophil counts for immune-related adverse events in metastatic NSCLC treated with immune checkpoint inhibitors#386527ARPHA OAI-PMH Endpoint
• Vaccine safety for individuals receiving immune checkpoint inhibitor therapy: A narrative review of current literature and recommendations for future research#4645Europe PMC
• CLEC2B-KLRB1 axis acts as an immune checkpoint, governing the exhaustion of CD8(+) T cells and their resistance to immune checkpoint blockade.#251063NCBI PubMed Central
• Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS#912776ClinicalTrials.gov
• Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors#1396003ClinicalTrials.gov
• Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors#875905ClinicalTrials.gov
• Association Of Immune Checkpoint Inhibitor Approval On Suicide Rates Among Patients With Cancer: A Pre-Post Analysis With Seer#167490EliScholar
• Investigating B Cell Function and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia.#305924ResearchSpace
• The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors#875335ClinicalTrials.gov
• Checkpoint Inhibitor-induced Liver Injury#1350274ClinicalTrials.gov